Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the record history; the government funding notice and the v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-02-11T09:16:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the revision version was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1.0%
    Check dated 2026-02-04T05:12:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI updates include showing a glossary toggle, enabling green highlights for additions and red highlights for deletions, and updating the revision label to v3.4.0, with a capitalization change from 'No FEAR Act data' to 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T02:13:17.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The record history gains a new revision entry v3.3.4 and removes the previous entry v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:28:20.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed.
    Difference
    0.3%
    Check dated 2025-12-23T09:09:40.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision 3.3.2 is now displayed on the page footer, replacing revision 3.3.1; this is a minor platform update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:46:24.000Z thumbnail image

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.